Douglas G. Cole
CIK 1486373 · last filed 2025-06-17
Douglas G. Cole is a corporate insider who has filed 52 SEC Form 4 insider transactions across 10 companies since 2010. The most recent filing, for FHTX, was dated Jun 17, 2025. Across all open-market trades the lifetime net is −$7.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $679.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$679.2K
10
52
-$7.92M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FHTX | Director | — | $4.18 | — | $0 | 5 | 2025-06-17 |
| SANA | Director | — | $2.68 | — | $0 | 6 | 2024-07-15 |
| Sigilon Therapeutics, Inc. (SGTX) Delisted | Director | — | $22.47 | — | $0 | 4 | 2023-08-11 |
| DNLI | Director | 26,564 | $21.66 | $575.4K | $0 | 8 | 2023-06-05 |
| QTRX | Director | 4,540 | $3.10 | $14.1K | $0 | 2 | 2019-01-04 |
| EDIT | Director | 3,171 | $2.50 | $7.9K | $0 | 3 | 2017-08-21 |
| AGIO | Director | 2,778 | $29.46 | $81.8K | $0 | 3 | 2016-08-11 |
| Receptos, Inc. (RCPT) Delisted | Director | — | — | — | $0 | 1 | 2013-07-19 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | Director | 0 | — | — | $0 | 2 | 2013-05-20 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Director | 23,909 | $15.00 | $358.6K | -$7.92M | 18 | 2011-05-16 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-17 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2024-07-15 | SANA | Grant (A) | — | $0 | EDGAR |
| 2024-06-28 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | SANA | Grant (A) | — | $0 | EDGAR |
| 2023-08-11 | Sigilon Therapeutics, Inc. (SGTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-06-22 | FHTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-09 | SANA | Grant (A) | — | $0 | EDGAR |
| 2023-06-05 | DNLI | Grant (A) | +4,216 | $0 | EDGAR |
| 2023-05-22 | Sigilon Therapeutics, Inc. (SGTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | FHTX | Grant (A) | — | $0 | EDGAR |